Ibrutinib induced leg ulcer successfully treated with platelet-rich plasma.
Sign Up to like & getrecommendations! Published in 2021 at "Dermatologic therapy"
DOI: 10.1111/dth.14874
Abstract: Dear Editor, Ibrutinib is an oral irreversible inhibitor of Bruton's tyrosine kinase, currently approved for the treatment of chronic lymphocytic leukemia (CLL). We report the first case of chronic ulcer in leg induced by Ibrutinib,… read more here.
Keywords: treatment; wound; platelet rich; ulcer ... See more keywords